-
1
-
-
0348048874
-
Diabetic retinopathy
-
COI: 1:CAS:528:DC%2BD2cXhtFGgug%3D%3D, PID: 14702427
-
Frank RN (2004) Diabetic retinopathy. N Engl J Med 350:48–58
-
(2004)
N Engl J Med
, vol.350
, pp. 48-58
-
-
Frank, R.N.1
-
2
-
-
84866092409
-
Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab
-
COI: 1:CAS:528:DC%2BC38XhsFyntLzL, PID: 22965591
-
Bressler SB, Qin H, Beck RW et al (2012) Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab. Arch Ophthalmol 130:1153–1161
-
(2012)
Arch Ophthalmol
, vol.130
, pp. 1153-1161
-
-
Bressler, S.B.1
Qin, H.2
Beck, R.W.3
-
3
-
-
84898420138
-
Contemporary management of diabetic retinopathy in Canada: from guidelines to algorithm guidance
-
PID: 24246998
-
Hooper P, Boucher MC, Colleaux K et al (2014) Contemporary management of diabetic retinopathy in Canada: from guidelines to algorithm guidance. Ophthalmologica 231:2–15
-
(2014)
Ophthalmologica
, vol.231
, pp. 2-15
-
-
Hooper, P.1
Boucher, M.C.2
Colleaux, K.3
-
4
-
-
62449171859
-
Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema
-
Diabetic Retinopathy Clinical Research N, Beck RW, Edwards AR et al (2009) Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol 127:245–251
-
(2009)
Arch Ophthalmol
, vol.127
, pp. 245-251
-
-
Beck, R.W.1
Edwards, A.R.2
-
5
-
-
77749330682
-
Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema
-
COI: 1:CAS:528:DC%2BC3cXktlSrur4%3D, PID: 20212197
-
Haller JA, Kuppermann BD, Blumenkranz MS et al (2010) Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol 128:289–296
-
(2010)
Arch Ophthalmol
, vol.128
, pp. 289-296
-
-
Haller, J.A.1
Kuppermann, B.D.2
Blumenkranz, M.S.3
-
6
-
-
0035847131
-
In vitro effects of dexamethasone on hypoxia-induced hyperpermeability and expression of vascular endothelial growth factor
-
COI: 1:CAS:528:DC%2BD3MXnsV2isg%3D%3D, PID: 11164380
-
Fischer S, Renz D, Schaper W, Karliczek GF (2001) In vitro effects of dexamethasone on hypoxia-induced hyperpermeability and expression of vascular endothelial growth factor. Eur J Pharmacol 411:231–243
-
(2001)
Eur J Pharmacol
, vol.411
, pp. 231-243
-
-
Fischer, S.1
Renz, D.2
Schaper, W.3
Karliczek, G.F.4
-
7
-
-
77952882990
-
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion
-
PID: 20417567
-
Haller JA, Bandello F, Belfort R Jr et al (2010) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117:1134–1146
-
(2010)
Ophthalmology
, vol.117
, pp. 1134-1146
-
-
Haller, J.A.1
Bandello, F.2
Belfort, R.3
-
8
-
-
84908118639
-
Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema
-
PID: 24907062
-
Boyer DS, Yoon YH, Belfort R Jr et al (2014) Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 121:1904–1914
-
(2014)
Ophthalmology
, vol.121
, pp. 1904-1914
-
-
Boyer, D.S.1
Yoon, Y.H.2
Belfort, R.3
-
9
-
-
85011649606
-
Dexamethasone intravitreal implant for chronic diabetic macular edema resistant to intravitreal bevacizumab treatment
-
Totan Y, Guler E, Guragac FB (2015) Dexamethasone intravitreal implant for chronic diabetic macular edema resistant to intravitreal bevacizumab treatment. Curr Eye Res 22:1–7
-
(2015)
Curr Eye Res
, vol.22
, pp. 1-7
-
-
Totan, Y.1
Guler, E.2
Guragac, F.B.3
-
10
-
-
84896489231
-
Dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema
-
COI: 1:CAS:528:DC%2BC2cXkslCmurk%3D, PID: 24356099
-
Dutra Medeiros M, Postorino M, Navarro R et al (2014) Dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema. Ophthalmologica 231(3):141–146
-
(2014)
Ophthalmologica
, vol.231
, Issue.3
, pp. 141-146
-
-
Dutra Medeiros, M.1
Postorino, M.2
Navarro, R.3
-
11
-
-
84936879975
-
Dexamethasone intravitreal implant for diabetic macular edema: indications for a PRN regimen of treatment
-
PID: 25633618
-
Panozzo G, Gusson E, Panozzo G, Dalla Mura G (2015) Dexamethasone intravitreal implant for diabetic macular edema: indications for a PRN regimen of treatment. Eur J Ophthalmol 25:347–351
-
(2015)
Eur J Ophthalmol
, vol.25
, pp. 347-351
-
-
Panozzo, G.1
Gusson, E.2
Panozzo, G.3
Dalla, M.G.4
-
12
-
-
84930473375
-
Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema
-
COI: 1:CAS:528:DC%2BC2MXps1Ols70%3D, PID: 25574787
-
Scaramuzzi M, Querques G, Spina CL, Lattanzio R, Bandello F (2015) Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema. Retina 35(6):1216–1222
-
(2015)
Retina
, vol.35
, Issue.6
, pp. 1216-1222
-
-
Scaramuzzi, M.1
Querques, G.2
Spina, C.L.3
Lattanzio, R.4
Bandello, F.5
-
13
-
-
85011647289
-
Efficacy of single-dose dexamethasone implantation in patients with persistent diabetic macular edema
-
Yorgun MA, Toklu Y, Mutlu M, Uysal BS, Cakmak HB (2015) Efficacy of single-dose dexamethasone implantation in patients with persistent diabetic macular edema. Int Ophthalmol 7:1–9
-
(2015)
Int Ophthalmol
, vol.7
, pp. 1-9
-
-
Yorgun, M.A.1
Toklu, Y.2
Mutlu, M.3
Uysal, B.S.4
Cakmak, H.B.5
-
14
-
-
79955558683
-
Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients
-
COI: 1:CAS:528:DC%2BC38XjtlOitb4%3D, PID: 21487341
-
Boyer DS, Faber D, Gupta S et al (2011) Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina 31:915–923
-
(2011)
Retina
, vol.31
, pp. 915-923
-
-
Boyer, D.S.1
Faber, D.2
Gupta, S.3
-
15
-
-
78049293726
-
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study
-
PID: 20855114
-
Nguyen QD, Shah SM, Khwaja AA et al (2010) Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology 117:2146–2151
-
(2010)
Ophthalmology
, vol.117
, pp. 2146-2151
-
-
Nguyen, Q.D.1
Shah, S.M.2
Khwaja, A.A.3
-
16
-
-
84938810401
-
A 12-month, single-masked, randomized controlled study of eyes with persistent diabetic macular edema after multiple anti-vegf injections to assess the efficacy of the dexamethasone-delayed delivery system as an adjunct to bevacizumab compared with continued bevacizumab monotherapy
-
COI: 1:CAS:528:DC%2BC2MXht1KgsL%2FF, PID: 25829346
-
Maturi RK, Bleau L, Saunders J, Mubasher M, Stewart MW (2015) A 12-month, single-masked, randomized controlled study of eyes with persistent diabetic macular edema after multiple anti-vegf injections to assess the efficacy of the dexamethasone-delayed delivery system as an adjunct to bevacizumab compared with continued bevacizumab monotherapy. Retina 35:1604–1614
-
(2015)
Retina
, vol.35
, pp. 1604-1614
-
-
Maturi, R.K.1
Bleau, L.2
Saunders, J.3
Mubasher, M.4
Stewart, M.W.5
-
17
-
-
84896359055
-
Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1)
-
COI: 1:CAS:528:DC%2BC2cXjtVOqtg%3D%3D, PID: 24384961
-
Mathew R, Pearce E, Muniraju R, Abdel-Hay A, Sivaprasad S (2014) Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1). Eye 28:318–326
-
(2014)
Eye
, vol.28
, pp. 318-326
-
-
Mathew, R.1
Pearce, E.2
Muniraju, R.3
Abdel-Hay, A.4
Sivaprasad, S.5
-
18
-
-
31644448419
-
Errors in retinal thickness measurements obtained by optical coherence tomography
-
PID: 16406542
-
Sadda SR, Wu Z, Walsh AC et al (2006) Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology 113:285–293
-
(2006)
Ophthalmology
, vol.113
, pp. 285-293
-
-
Sadda, S.R.1
Wu, Z.2
Walsh, A.C.3
-
19
-
-
84864601616
-
Intravitreal dexamethasone implant in patients with persistent diabetic macular edema
-
COI: 1:CAS:528:DC%2BC38XhtFWntrbI, PID: 22310491
-
Zucchiatti I, Lattanzio R, Querques G et al (2012) Intravitreal dexamethasone implant in patients with persistent diabetic macular edema. Ophthalmologica 228:117–122
-
(2012)
Ophthalmologica
, vol.228
, pp. 117-122
-
-
Zucchiatti, I.1
Lattanzio, R.2
Querques, G.3
-
20
-
-
33847130442
-
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema
-
Diabetic Retinopathy Clinical Research N, Browning DJ, Glassman AR et al (2007) Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 114:525–536
-
(2007)
Ophthalmology
, vol.114
, pp. 525-536
-
-
Browning, D.J.1
Glassman, A.R.2
-
21
-
-
77954733197
-
Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema
-
PID: 20616686
-
Blumenkranz MS, Haller JA, Kuppermann BD et al (2010) Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema. Retina 30:1090–1094
-
(2010)
Retina
, vol.30
, pp. 1090-1094
-
-
Blumenkranz, M.S.1
Haller, J.A.2
Kuppermann, B.D.3
-
22
-
-
84937739093
-
Diabetic macular edema: pathophysiology and novel therapeutic targets
-
PID: 25935789
-
Das A, McGuire PG, Rangasamy S (2015) Diabetic macular edema: pathophysiology and novel therapeutic targets. Ophthalmology 122:1375–1394
-
(2015)
Ophthalmology
, vol.122
, pp. 1375-1394
-
-
Das, A.1
McGuire, P.G.2
Rangasamy, S.3
-
23
-
-
42449135678
-
Immunological mechanisms in the pathogenesis of diabetic retinopathy
-
COI: 1:CAS:528:DC%2BD1cXkslKiu78%3D, PID: 18340447
-
Adamis AP, Berman AJ (2008) Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol 30:65–84
-
(2008)
Semin Immunopathol
, vol.30
, pp. 65-84
-
-
Adamis, A.P.1
Berman, A.J.2
-
24
-
-
84871618314
-
Repeated intravitreal dexamethasone implant (Ozurdex(R)) for retinal vein occlusion
-
COI: 1:CAS:528:DC%2BC38XhvV2gsb7I, PID: 23006995
-
Querques L, Querques G, Lattanzio R, Gigante SR, Del Turco C, Corradetti G et al (2013) Repeated intravitreal dexamethasone implant (Ozurdex(R)) for retinal vein occlusion. Ophthalmologica 229:21–25
-
(2013)
Ophthalmologica
, vol.229
, pp. 21-25
-
-
Querques, L.1
Querques, G.2
Lattanzio, R.3
Gigante, S.R.4
Del Turco, C.5
Corradetti, G.6
|